Incidence of Amlodipine-induced Gingival Overgrowth in the Rural Population of Loni
Overview
Authors
Affiliations
Aims: Since the incidence of gingival overgrowth induced by amlodipine remains poorly defined, this study was carried out with an aim to determine the incidence.
Materials And Methods: Dental patients who received amlodipine (N = 115), for more than 3 months were studied to determine the drug-induced gingival overgrowth. Clinical diagnosis of drug-induced overgrowth was verified by disappearance or decreased severity of gingival overgrowth after withdrawal of the causative drug.
Results: The prevalence rate of amlodipine-induced gingival hyperplasia among experimental patients was 3.4%, while it was not observed among the control subjects. Oral examination revealed gingival overgrowth as a lobular or nodular enlargement on interdental papilla located in the anterior interproximal regions.
Conclusions: In this study, there was a significant relationship between gingival inflammation resulting from dental plaque and drug dosage, and hyperplasia.
Amlodipine-Induced Gingival Hyperplasia in a Young Male with Stage 5 Chronic Kidney Disease.
John K, Mishra A, Gunasekaran K, Iyyadurai R Case Rep Nephrol. 2020; 2020:7801546.
PMID: 32099704 PMC: 7038384. DOI: 10.1155/2020/7801546.
Gaur S, Agnihotri R J Clin Exp Dent. 2018; 10(6):e610-e619.
PMID: 29930781 PMC: 6005094. DOI: 10.4317/jced.54715.
Mohn E, Kern H, Saltzman E, Mitmesser S, McKay D Pharmaceutics. 2018; 10(1).
PMID: 29558445 PMC: 5874849. DOI: 10.3390/pharmaceutics10010036.
Amlodipine-induced gingival overgrowth in a child after liver transplant.
Guollo A, Molina Vivas A, Lopes R, Porta G, Alves F Autops Case Rep. 2016; 6(3):47-51.
PMID: 27818959 PMC: 5087984. DOI: 10.4322/acr.2016.041.